Hot Products

Phillygenin
Catalog No: CFN90511

Phillyrin, (+)-Phillygenin, and (-)-phillygenin exert the strongest inhibitory activities on NO production with IC(50) values.

Phillyrin
Catalog No: CFN99998

Phillyrin is a novel AMPK activator, has anti-obesity effects in nutritive obesity mice, it can prevent lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation. Phillyrin may be a new preventive agent of acute lung injury in the clinical setting, it potentially contributes to the suppression of the activation of MAPK and NF-κB pathways, it also has protective effects on H2O2-induced oxidative stress and apoptosis in PC12 cells.

Phloracetophenone 4'-O-glucoside
Catalog No: CFN96153

Reference standards.

Phloretic acid
Catalog No: CFN90888

Phloretic acid may have antifungal activity.

Phloretin
Catalog No: CFN97040

Phloretin may potentially be an immunomodulator by impairing the activation and function of DCs, it is effective in preventing estrogen deficiency-induced osteoclastogenic resorption. Phloretin has antimicrobial activity against the Gram negative bacteria Salmonella typhimurium ATCC 13311. It has a wide spectrum of targets including ASK-1-MAPK, Smac, capase.

Phloretin 3',5'-Di-C-glucoside
Catalog No: CFN95306

Phloretin 3',5'-Di-C-glucoside is able to inhibit growth of Gram positive bacteria.

Phlorin
Catalog No: CFN98343

Reference standards.

Phlorizin
Catalog No: CFN97038

Phlorizin is a non-selective SGLT inhibitor with Kis of 300 and 39 nM for hSGLT1 and hSGLT2, respectively. Phlorizin is also a Na+/K+-ATPase inhibitor. Phlorizin may be a novel therapeutic approach for the treatment of diabetic nephrolog, it protects mice from diabetic nephrology. Phlorizin prevents ventricular tachyarrhythmia through the improvement of impulse conduction slowing during ischemia.

Phlorizin dihydrate
Catalog No: CFN90442

Phlorizin dihydrate can significantly inhibit oxidative DNA damage.

p-Hydroxy-cinnamic acid
Catalog No: CFN98179

p-Hydroxy-cinnamic acid may have in vitro antimalarial activity. p-Hydroxycinnamic acid and β-cryptoxanthin have anti-osteoporotic properties in vivo, they can antagonize NF-κB activation in MC3T3 preosteoblastic cells。